Exosome engineering in cell therapy and drug delivery
- PMID: 36609717
- PMCID: PMC9823267
- DOI: 10.1007/s10787-022-01115-7
Exosome engineering in cell therapy and drug delivery
Abstract
Cell-derived exosomes have opened new horizons in modern therapy for advanced drug delivery and therapeutic applications, due to their key features such as low immunogenicity, high physicochemical stability, capacity to penetrate into tissues, and the innate capacity to communicate with other cells over long distances. Exosome-based liquid biopsy has been potentially used for the diagnosis and prognosis of a range of disorders. Exosomes deliver therapeutic agents, including immunological modulators, therapeutic drugs, and antisense oligonucleotides to certain targets, and can be used as vaccines, though their clinical application is still far from reality. Producing exosomes on a large-scale is restricted to their low circulation lifetime, weak targeting capacity, and inappropriate controls, which need to be refined before being implemented in practice. Several bioengineering methods have been used for refining therapeutic applications of exosomes and promoting their effectiveness, on the one hand, and addressing the existing challenges, on the other. In the short run, new diagnostic platforms and emerging therapeutic strategies will further develop exosome engineering and therapeutic potential. This requires a thorough analysis of exosome engineering approaches along with their merits and drawbacks, as outlined in this paper. The present study is a comprehensive review of novel techniques for exosome development in terms of circulation time in the body, targeting capacity, and higher drug loading/delivery efficacies.
Keywords: Cargo incorporation; Exosome; Extracellular vesicles; Targeted delivery; Therapeutic applications.
© 2023. The Author(s), under exclusive licence to Springer Nature Switzerland AG.
Conflict of interest statement
The authors have no relevant financial or non-financial interests to disclose and declare no conflict of interest.
Figures



Similar articles
-
Engineering Approaches for Exosome Cargo Loading and Targeted Delivery: Biological versus Chemical Perspectives.ACS Biomater Sci Eng. 2024 Oct 14;10(10):5960-5976. doi: 10.1021/acsbiomaterials.4c00856. Epub 2024 Jun 28. ACS Biomater Sci Eng. 2024. PMID: 38940421 Review.
-
Engineered Exosome for Drug Delivery: Recent Development and Clinical Applications.Int J Nanomedicine. 2023 Dec 23;18:7923-7940. doi: 10.2147/IJN.S444582. eCollection 2023. Int J Nanomedicine. 2023. PMID: 38152837 Free PMC article. Review.
-
Exosome engineering for efficient and targeted drug delivery: Current status and future perspective.J Physiol. 2023 Nov;601(22):4853-4872. doi: 10.1113/JP282799. Epub 2022 Jun 2. J Physiol. 2023. PMID: 35570717 Review.
-
Exosomes: Cell-Derived Nanoplatforms for the Delivery of Cancer Therapeutics.Int J Mol Sci. 2020 Dec 22;22(1):14. doi: 10.3390/ijms22010014. Int J Mol Sci. 2020. PMID: 33374978 Free PMC article. Review.
-
Exosome-Based Drug Delivery: Translation from Bench to Clinic.Pharmaceutics. 2023 Jul 29;15(8):2042. doi: 10.3390/pharmaceutics15082042. Pharmaceutics. 2023. PMID: 37631256 Free PMC article. Review.
Cited by
-
Maximizing liposome tumor delivery by hybridizing with tumor-derived extracellular vesicles.Nanoscale. 2024 Sep 12;16(35):16652-16663. doi: 10.1039/d4nr02191f. Nanoscale. 2024. PMID: 39171636
-
Nucleic acid-based nanotherapeutics for treating sepsis and associated organ injuries.Theranostics. 2024 Jul 16;14(11):4411-4437. doi: 10.7150/thno.98487. eCollection 2024. Theranostics. 2024. PMID: 39113804 Free PMC article. Review.
-
Fertility Protection, A Novel Concept: Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes Protect against Chemotherapy-Induced Testicular Cytotoxicity.Int J Mol Sci. 2023 Dec 20;25(1):60. doi: 10.3390/ijms25010060. Int J Mol Sci. 2023. PMID: 38203232 Free PMC article.
-
New Origins of Yeast, Plant and Bacterial-Derived Extracellular Vesicles to Expand and Advance Compound Delivery.Int J Mol Sci. 2024 Jun 28;25(13):7151. doi: 10.3390/ijms25137151. Int J Mol Sci. 2024. PMID: 39000260 Free PMC article. Review.
-
Edible Plant-Derived Extracellular Vesicles for Oral mRNA Vaccine Delivery.Vaccines (Basel). 2024 Feb 15;12(2):200. doi: 10.3390/vaccines12020200. Vaccines (Basel). 2024. PMID: 38400183 Free PMC article. Review.
References
-
- Ahmad M, Minhas MU, Sohail M, Faisal M, Rashid H. Comprehensive review on magnetic drug delivery systems: a novel approach for drug targeting. J Pharm Altern Med. 2013;2(4):13–21.
-
- Akuma P, Okagu OD, Udenigwe CC. Naturally occurring exosome vesicles as potential delivery vehicle for bioactive compounds. Front Sustain Food Syst. 2019;3:23. doi: 10.3389/fsufs.2019.00023. - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources